Shots:
- The USDA has approved Elanco‘s TruCan Ultra Lyme-L4 to protect dogs against both Lyme disease and leptospirosis, expanding its extensive TruCan Ultra Portfolio
- TruCan Ultra Lyme-L4 uses Elanco’s PureFil Tech to reduce vaccination reactions & is available in a 1/2mL formulation that delivers the same broad protection as the 1 mL version, enabling comprehensive coverage with fewer injections
- TruCan Ultra Lyme vaccines showed 92.2% efficacy against natural infection in highly endemic areas & 100% efficacy in laboratory studies, with the single-injection combination vaccine designed to improve the experience for pets, owners, & veterinary staff
Ref: PRnewswire | Image: Elanco | Press Release
Related News: Elanco Animal Health Reports the USDA Approval of Befrena (Tirnovetmab) for Canine Allergic and Atopic Dermatitis
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
